<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hematoloji Araştırması &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/hematoloji-arastirmasi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Jan 2026 15:58:12 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Hematoloji Araştırması &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Transfusion Thresholds Impact Quality of Life in MDS</title>
		<link>https://bioengineer.org/transfusion-thresholds-impact-quality-of-life-in-mds/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jan 2026 15:57:46 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Hematoloji Araştırması]]></category>
		<category><![CDATA[Kan Transfüzyonu]]></category>
		<category><![CDATA[MDS]]></category>
		<category><![CDATA[Myelodysplastic syndromes]]></category>
		<category><![CDATA[Quality of Life]]></category>
		<category><![CDATA[Red blood cell transfusion]]></category>
		<category><![CDATA[systematic review]]></category>
		<category><![CDATA[Transfusion thresholds]]></category>
		<category><![CDATA[Transfüzyon Stratejileri]]></category>
		<category><![CDATA[yaşam kalitesi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/transfusion-thresholds-impact-quality-of-life-in-mds/</guid>

					<description><![CDATA[In a pivotal exploration of transfusion strategies, a groundbreaking study has emerged, focusing on the hematological realm’s often-debated themes: liberal versus restrictive red blood cell (RBC) transfusion thresholds. This critical assessment delves into the impact of these different transfusion strategies on the overall quality of life in patients grappling with myelodysplastic syndromes (MDS), a group [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">321160</post-id>	</item>
	</channel>
</rss>
